相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Transient Receptor Potential Channels and Itch
Omar Mahmoud et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Histamine Sensitization of the Voltage-Gated Sodium Channel Nav1.7 Contributes to Histaminergic Itch in Mice
Shaoheng Li et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Involvement of Sensory Neurone-TRPV4 in Acute and Chronic Itch Behaviours
Qiaojuan Zhang et al.
ACTA DERMATO-VENEREOLOGICA (2022)
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study
Diego Alvarado et al.
ALLERGY (2022)
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)
J. Gutermuth et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies
K. Kabashima et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)
Chun Wook Park et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Circuit Mechanisms of Itch in the Brain
Di Mu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis
J. P. Thyssen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase
E. Weisshaar et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Novel functions of S1P in chronic itchy and inflammatory skin diseases
N. Gray et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Structural Studies of Mas-Related G Protein-Coupled Receptors
E. Lerner
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Role of TRP ion channels in pruritus
Parth Shirolkar et al.
NEUROSCIENCE LETTERS (2022)
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial
H. Saeki et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb
Yannick Miron et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis A Randomized Clinical Trial
Ichiei Narita et al.
JAMA NETWORK OPEN (2022)
Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases
Han-Bi Kim et al.
BIOMEDICINES (2022)
The Effects of Cannabinoid Agonist, Heat Shock Protein 90 and Nitric Oxide Synthase Inhibitors on Increasing IL-13 and IL-31 Levels in Chronic Pruritus
Zeynep Gizem Todurga Seven et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits
Brian S. Kim et al.
EXPERIMENTAL DERMATOLOGY (2022)
Immunotargets and Therapy for Prurigo Nodularis
Angelina Labib et al.
IMMUNOTARGETS AND THERAPY (2022)
Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial
J. I. Silverberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)
A. Wollenberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Novel insights into the TRPV3-mediated itch in atopic dermatitis
Ciara Larkin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases
Monica Thapaliya et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2021)
Cannabinoids interaction with transient receptor potential family and implications in the treatment of rosacea
Kieran B. Garbutcheon-Singh et al.
DERMATOLOGIC THERAPY (2021)
Cutaneous Gene Expression in Primates with Itch
Leigh A. Nattkemper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial
S. E. Welsh et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Periostin, an Emerging Player in Itch Sensation
Takashi Hashimoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
A plant-derived TRPV3 inhibitor suppresses pain and itch
Yalan Han et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
Mark G. Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice
Katharina Wolf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
Marcus Maurer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis
Marcella Massimini et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib
Eric L. Simpson et al.
DERMATITIS (2021)
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Perez-Jeldres et al.
DRUGS (2021)
Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated
Naoko Kanda
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Role of TRPA1 in Skin Physiology and Pathology
Roberto Maglie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
Hiroyuki Ogasawara et al.
CELLS (2021)
Atopic Dermatitis
Sonja Staender
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Thomas Bieber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch
Raj P. Fadadu et al.
JAMA DERMATOLOGY (2021)
Pruritus as a Distinctive Feature of Type 2 Inflammation
Simone Garcovich et al.
VACCINES (2021)
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
Brian S. Kim et al.
DERMATITIS (2021)
The pruritogenic role of the type 2 immune response in diseases associated with chronic itch
Giuseppe Ingrasci et al.
EXPERIMENTAL DERMATOLOGY (2021)
JAK inhibitors in the treatment of atopic dermatitis
Raj Chovatiya et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
28588 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study
Matthew Zirwas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis
Linda Stein Gold et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
26622 The impact of neuropathic itch on patients’ quality of life
Zoe M. Lipman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Approach to the Patient with Chronic Pruritus
Zoe M. Lipman et al.
MEDICAL CLINICS OF NORTH AMERICA (2021)
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial
Lawrence F. Eichenfield et al.
JAMA DERMATOLOGY (2021)
TRPV1 and TRPA1 Channels Are Both Involved Downstream of Histamine-Induced Itch
Jenny Wilzopolski et al.
BIOMOLECULES (2021)
The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development
Kazufumi Kunimura et al.
INTERNATIONAL IMMUNOLOGY (2021)
Structure, function and pharmacology of human itch GPCRs
Can Cao et al.
NATURE (2021)
Pathophysiologic mechanisms of itch in bullous pemphigoid
Takashi Hashimoto et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial
Albert S. Chiou et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA-15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopic dermatitis
Hidehisa Saeki et al.
JOURNAL OF DERMATOLOGY (2020)
Mechanisms of Itch in Stasis Dermatitis: Significant Role of IL-31 from Macrophages
Takashi Hashimoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Role of macrophage TRPV4 in inflammation
Bidisha Dutta et al.
LABORATORY INVESTIGATION (2020)
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
Steven Fishbane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes
Jiahui Zhao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
David M. Pariser et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Cannabinoids for the treatment of chronic pruritus: A review
Christina Avila et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS
Jonathan I. Silverberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
Sonja Staender et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo
Jennifer Gherardini et al.
PLOS ONE (2020)
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis A Phase 2b Randomized Clinical Trial
Emma Guttman-Yassky et al.
JAMA DERMATOLOGY (2020)
Enhanced Thermal Sensitivity of TRPV3 in Keratinocytes Underlies Heat-Induced Pruritogen Release and Pruritus in Atopic Dermatitis
Seong Hoon Seo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch
Santosh K. Mishra et al.
CELL REPORTS (2020)
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Jonathan Silverberg et al.
JAMA DERMATOLOGY (2020)
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis
Hidemi Nakagawa et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
Steven Fishbane et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Eric L Simpson et al.
LANCET (2020)
Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates
Huiping Ding et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kenji Kabashima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Central circuit mechanisms of itch
Xiao-Jun Chen et al.
NATURE COMMUNICATIONS (2020)
Substance P Release by Sensory Neurons Triggers Dendritic Cell Migration and Initiates the Type-2 Immune Response to Allergens
Caroline Perner et al.
IMMUNITY (2020)
Benralizumab for Chronic Spontaneous Urticaria
Jonathan A. Bernstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of apremilast in chronic pruritus of unknown origin: A proof-of-concept, phase 2a, open-label, single-arm clinical trial
Marie Clark et al.
HEALTH SCIENCE REPORTS (2020)
The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
Julie Sophie Hohwu Elsner et al.
ACTA DERMATO-VENEREOLOGICA (2020)
Possible roles of basophils in chronic itch
Takashi Hashimoto et al.
EXPERIMENTAL DERMATOLOGY (2019)
A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis
Johnny Peppers et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
Sonja Staender et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study
Abdelrady S. Ibrahim et al.
MINERVA ANESTESIOLOGICA (2019)
A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain
Dustin P. Green et al.
NEURON (2019)
Periostin: An emerging biomarker for allergic diseases
Kenji Izuhara et al.
ALLERGY (2019)
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus
S. Staender et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch
James Meixiong et al.
IMMUNITY (2019)
MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus
James Meixiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MRGPRX4 is a bile acid receptor for human cholestatic itch
Huasheng Yu et al.
ELIFE (2019)
Interleukin-4 and interleukin-13 evoke scratching behaviour in mice
Michelle Campion et al.
EXPERIMENTAL DERMATOLOGY (2019)
3′-O-Methylorobol Inhibits the Voltage-Gated Sodium Channel Nav1.7 with Anti-Itch Efficacy in A Histamine-Dependent Itch Mouse Model
Fan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation
Nadine Serhan et al.
NATURE IMMUNOLOGY (2019)
Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
Navin Goyal et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis A Phase 2 Randomized Clinical Trial
Melinda J. Gooderham et al.
JAMA DERMATOLOGY (2019)
Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial
Y. W. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Role of P2X3 receptors in scratching behavior in mouse models
Miho Shiratori-Hayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Eric L. Simpson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Identification of a bilirubin receptor that may mediate a component of cholestatic itch
James Meixiong et al.
ELIFE (2019)
Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria
Jason Kihyuk Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
Takashi Hashimoto et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Regulation of Pain and Itch by TRP Channels
Carlene Moore et al.
NEUROSCIENCE BULLETIN (2018)
Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor
Gil Yosipovitch et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant
Tatevik Ohanyan et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist
K. A. Bilir et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Role of mast cells and basophils in pruritus
Martin Steinhoff et al.
IMMUNOLOGICAL REVIEWS (2018)
Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: A randomized single-blinded pilot study
Taige Cao et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2018)
Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch
Jialie Luo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch
Leigh A. Nattkemper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Identification of N-{cis-3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)aminolcyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases
Michael L. Vazquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Prevalence and Characteristics of Pruritus and Association With Quality of Life in People Living With HIV: A Cross-Sectional Study
Thomas Xu et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Phosphodiesterase 4 inhibitors
Rema Zebda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
Gil Yosipovitch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
miRNA-711 Binds and Activates TRPA1 Extracellularly to Evoke Acute and Chronic Pruritus
Qingjian Han et al.
NEURON (2018)
Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization
Hjalte Holm Andersen et al.
PAIN (2018)
Antipruritic Effects of Botulinum Neurotoxins
Parisa Gazerani
TOXINS (2018)
Keratinocytes mediate innocuous and noxious touch via ATP-P2X4 signaling
Francie Moehring et al.
ELIFE (2018)
Itch induced by peripheral mu opioid receptors is dependent on TRPV1-expressing neurons and alleviated by channel activation
Helvira Melo et al.
SCIENTIFIC REPORTS (2018)
Itch: From mechanism to (novel) therapeutic approaches
Gil Yosipovitch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
A pivotal role for the activation of TRPV3 channel in itch sensations induced by the natural skin sensitizer carvacrol
Ting-ting Cui et al.
ACTA PHARMACOLOGICA SINICA (2018)
TRP Channels as Drug Targets to Relieve Itch
Zili Xie et al.
PHARMACEUTICALS (2018)
Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1
Wichayapha Manorak et al.
RESPIRATORY RESEARCH (2018)
Efficacy of a topical proteinase-activated receptor-2 inhibitor on cowhage-induced pruritus: a randomized placebo-controlled double-blind study
T. Cao et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin
Takanori Hidaka et al.
NATURE IMMUNOLOGY (2017)
Antioxidants Attenuate Acute and Chronic Itch: Peripheral and Central Mechanisms of Oxidative Stress in Pruritus
Feng-Ming Zhou et al.
NEUROSCIENCE BULLETIN (2017)
Substance P activates Mas-related G protein-coupled receptors to induce itch
Ehsan Azimi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Synergistic antipruritic effects of gamma aminobutyric acid A and B agonists in a mouse model of atopic dermatitis
Ferda Cevikbas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis
Susmit Suvas
JOURNAL OF IMMUNOLOGY (2017)
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
Susan H. Smith et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity
Russell F. Graceffa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Up-regulated expression of substance P in CD8+ T cells and NK1R on monocytes of atopic dermatitis
Zenan Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
In silico design of novel probes for the atypical opioid receptor MRGPRX2
Katherine Lansu et al.
NATURE CHEMICAL BIOLOGY (2017)
The molecular and cellular mechanisms of itch and the involvement of TRP channels in the peripheral sensory nervous system and skin
Hiroki Kittaka et al.
ALLERGOLOGY INTERNATIONAL (2017)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus
Vandana S. Mathur et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Landon K. Oetjen et al.
CELL (2017)
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice
Anthony J. Roecker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K. Mollanazar et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
The pathogenesis of Prurigo nodularis - Super-Itch' in exploration
C. Zeidler et al.
EUROPEAN JOURNAL OF PAIN (2016)
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin
Leigh A. Nattkemper et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
Jeffrey M. Sobell et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Pathophysiology of pruritus in primary localized cutaneous amyloidosis
H. L. Tey et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Health-related quality of life in haemodialysis patients suffering from chronic itch: results from GEHIS (German Epidemiology Haemodialysis Itch Study)
Melanie Weiss et al.
QUALITY OF LIFE RESEARCH (2016)
Histamine Released from Epidermal Keratinocytes Plays a Role in α-Melanocyte-Stimulating Hormone-Induced Itching in Mice
Kyoko Shimizu et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities
Filiberto Cedeno-Laurent et al.
CLINICAL IMMUNOLOGY (2015)
Health-Related Quality of Life in Chronic Pruritus: An Analysis Related to Disease Etiology, Clinical Skin Conditions and Itch Intensity
Benjamin Warlich et al.
DERMATOLOGY (2015)
A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves
Hisashi Wakita et al.
EXPERIMENTAL DERMATOLOGY (2015)
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model
Hyun Jong Kim et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Florence J. Dalgard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission
Takayo Haruna et al.
PHARMACOLOGY (2015)
Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin
T. Mineshige et al.
VETERINARY PATHOLOGY (2015)
Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates
Heeseung Lee et al.
SCIENTIFIC REPORTS (2015)
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
Yoko Murata et al.
JOURNAL OF DERMATOLOGY (2015)
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
Benjamin D. McNeil et al.
NATURE (2015)
TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
Michael J. Caterina
ACS CHEMICAL NEUROSCIENCE (2014)
Role of AhR/ARNT system in skin homeostasis
Masutaka Furue et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Itch and nerve fibers with special reference to atopic dermatitis: Therapeutic implications
Mitsutoshi Tominaga et al.
JOURNAL OF DERMATOLOGY (2014)
Substance P Is Upregulated in the Serum of Patients with Chronic Spontaneous Urticaria
Martin Metz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Paroxysmal itch caused by gain-of-function Nav1.7 mutation
Grazia Devigili et al.
PAIN (2014)
N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients
Chao Yuan et al.
CLINICAL INTERVENTIONS IN AGING (2014)
The Histamine H4 Receptor Antagonist, JNJ 39758979, Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects
Alexa Kollmeier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
The role of histamine in neurogenic inflammation
A. C. Rosa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
Sarah R. Wilson et al.
CELL (2013)
Chronic Pruritus
Gil Yosipovitch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways
Xiaoyou Shi et al.
REGULATORY PEPTIDES (2013)
Exome Sequencing Reveals Mutations in TRPV3 as a Cause of Olmsted Syndrome
Zhimiao Lin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Peter Schafer
BIOCHEMICAL PHARMACOLOGY (2012)
Discovery of S-777469: An orally available CB2 agonist as an antipruritic agent
Masahide Odan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The use of botulinum toxin in the management of burns itching: Preliminary results
N. Akhtar et al.
BURNS (2012)
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
Miho Masuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pruriceptive spinothalamic tract neurons: physiological properties and projection targets in the primate
Steve Davidson et al.
JOURNAL OF NEUROPHYSIOLOGY (2012)
A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch
Alexandru D. P. Papoiu et al.
NEUROIMAGE (2012)
Protease-activated receptor 2 signaling in inflammation
Andrea S. Rothmeier et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice
Tong Liu et al.
NEUROSCIENCE BULLETIN (2012)
Expression of tachykinins and their receptors in plaque psoriasis with pruritus
B. Amatya et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: Roles of Mas-related genes MrgX1 and MrgX2
Sakeen W. Kashem et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Tetracyclines Modulate Protease-Activated Receptor 2-Mediated Proinflammatory Reactions in Epidermal Keratinocytes
Chika Ishikawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin
P. Gazerani et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair
Linda Jackson-Boeters et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase
Won-Sik Shim et al.
JOURNAL OF NEUROSCIENCE (2007)
Substance P receptor expression in human skin keratinocytes and fibroblasts
J. -Y. Liu et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes
Attila Dallos et al.
NEUROPEPTIDES (2006)
Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions
M Tauchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin
M Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Emollients with endocannabinoids in the treatment of uremic pruritus: Discussion of the therapeutic options
JC Szepietowski et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
N Clayton et al.
PAIN (2002)
Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison
U Wollina et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2002)
The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor
GJ Burbach et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells
PR Rogers et al.
IMMUNITY (2001)
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
M Steinhoff et al.
NATURE MEDICINE (2000)